Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Over the past few years, Abbott Laboratories (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those losses by quickly developing and marketing COVID-19 diagnostic tests. However, sales of these products started declining as the outbreak receded, leading to more uneven revenue growth for the company. Throughout it all, one of Abbott Laboratories' segments has been its best and most consistent growth driver: Diabetes care. Abbott Labs recently added a new product to this business that could help improve its performance. Let's review the details and find out what it all means for investors. The leader in continuous glucose monitoring Abbott Labs' key product line in its diabetes care segment is the FreeStyle Libre, a portfolio of continuous glucose monitoring (CGM) devices that allow diabetes patients to keep track of their blood glucose levels. Libre sales have been on fire. They gener
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Point of Care Testing Market Research 2024: A $79.3 Billion Industry by 2031, Driven by Technological Innovations and Rising Chronic Disease Prevalence [Yahoo! Finance]Yahoo! Finance
- Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - TENS Segment Dominates as Demand for Chronic Pain Management Grows [Yahoo! Finance]Yahoo! Finance
- Covid-19 rapid antigen tests rapidly taking off [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- United States Cardiovascular Surgery Devices Market Outlook to 2033: Focus on Beating Heart Surgery Systems and Perfusion Disposables [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website